1. Home
  2. DGLY vs GLTO Comparison

DGLY vs GLTO Comparison

Compare DGLY & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGLY
  • GLTO
  • Stock Information
  • Founded
  • DGLY 2004
  • GLTO 2011
  • Country
  • DGLY United States
  • GLTO Denmark
  • Employees
  • DGLY N/A
  • GLTO N/A
  • Industry
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGLY Technology
  • GLTO Health Care
  • Exchange
  • DGLY Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • DGLY 4.2M
  • GLTO 4.0M
  • IPO Year
  • DGLY N/A
  • GLTO 2020
  • Fundamental
  • Price
  • DGLY $2.47
  • GLTO $3.29
  • Analyst Decision
  • DGLY
  • GLTO Buy
  • Analyst Count
  • DGLY 0
  • GLTO 1
  • Target Price
  • DGLY N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • DGLY 1.3M
  • GLTO 86.7K
  • Earning Date
  • DGLY 05-21-2025
  • GLTO 05-08-2025
  • Dividend Yield
  • DGLY N/A
  • GLTO N/A
  • EPS Growth
  • DGLY N/A
  • GLTO N/A
  • EPS
  • DGLY N/A
  • GLTO N/A
  • Revenue
  • DGLY $18,596,715.00
  • GLTO N/A
  • Revenue This Year
  • DGLY N/A
  • GLTO N/A
  • Revenue Next Year
  • DGLY N/A
  • GLTO N/A
  • P/E Ratio
  • DGLY N/A
  • GLTO N/A
  • Revenue Growth
  • DGLY N/A
  • GLTO N/A
  • 52 Week Low
  • DGLY $1.93
  • GLTO $2.01
  • 52 Week High
  • DGLY $320.00
  • GLTO $16.07
  • Technical
  • Relative Strength Index (RSI)
  • DGLY 23.18
  • GLTO 59.33
  • Support Level
  • DGLY $2.23
  • GLTO $3.05
  • Resistance Level
  • DGLY $2.73
  • GLTO $3.49
  • Average True Range (ATR)
  • DGLY 0.59
  • GLTO 0.26
  • MACD
  • DGLY 3.20
  • GLTO 0.04
  • Stochastic Oscillator
  • DGLY 16.17
  • GLTO 75.76

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: